Emergence of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.
Bienvenu
B
B
Service de Néphrologie, Hôpital Saint Louis, Paris, France.
Thervet
E
E
Bedrossian
J
J
Scieux
C
C
Mazeron
M C
MC
Thouvenot
D
D
Legendre
C
C
D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000187:drug effects*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D015774:Ganciclovir / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D015774:Ganciclovir